Literature DB >> 6617413

The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study.

K M West, M M Ahuja, P H Bennett, A Czyzyk, O M De Acosta, J H Fuller, B Grab, V Grabauskas, R J Jarrett, K Kosaka.   

Abstract

In 9 of the 14 national samples of diabetic patients assembled for the WHO Multinational Study of Vascular Disease in Diabetes additional laboratory data made it possible to relate manifestations of macrovascular disease to blood glucose concentrations as well as to diabetes duration and to other potential determinants. In five of the samples, serum triglyceride concentrations were also measured and were included in simple and multivariate analyses. Ischemic heart disease defined from Minnesota-coded EKGs and standardized WHO questionnaires was more strongly associated with serum triglyceride concentrations than with serum cholesterol concentrations, an association less notable in non-insulin-dependent diabetic patients. Ischemic heart disease was not related to the single fasting plasma glucose estimated for this study. Stroke and amputation were much more strongly related to the known duration of diabetes than was ischemic heart disease, and they were both related to blood glucose concentration measured at the time of study. Despite major variation in arterial disease prevalence rates between collaborating centers, risk for diabetic women appeared to equal that for diabetic men. The major variation in arterial disease prevalence between national groups could be accounted for only in part by the risk factors studied. Other factors, genetic or more likely environmental, are likely to contribute to the variation in arterial disease susceptibility and, if definable, may be potentially preventable.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6617413     DOI: 10.2337/diacare.6.4.361

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  44 in total

Review 1.  Management of diabetic nephropathy.

Authors:  L Foggensteiner; S Mulroy; J Firth
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

Review 2.  Coronary heart disease in diabetes mellitus--antecedents and associations.

Authors:  P H Winocour
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 3.  Specific lipid lowering therapy in the management of diabetes.

Authors:  P N Durrington
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 4.  The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis.

Authors:  S C Bain; P M Dodson
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

5.  [Tackling lipaemia in diabetes mellitus in primary care].

Authors:  C Llor Vilà
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

6.  Oxidative stress and triglycerides as predictors of subclinical atherosclerosis in prediabetes.

Authors:  Hayder A Al-Aubaidy; Herbert F Jelinek
Journal:  Redox Rep       Date:  2014-01-13       Impact factor: 4.412

7.  Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

Authors:  A Fontbonne; E Eschwège; F Cambien; J L Richard; P Ducimetière; N Thibult; J M Warnet; J R Claude; G E Rosselin
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

8.  The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis.

Authors:  K Tsutsumi; Y Inoue; A Shima; K Iwasaki; M Kawamura; T Murase
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

9.  [Persisting hyperlipidemias as risk factors of diabetic macroangiopathy].

Authors:  K H Vogelberg; G Meurers
Journal:  Klin Wochenschr       Date:  1986-06-02

10.  Synthesis and Anti-hyperlipidemic Activity of 3H-benzo [4, 5] thieno [2, 3-d] [1, 2, 3] triazin-4-ones: Possible Mechanism of Altered Lipid Metabolism.

Authors:  Gollapalle L Viswanatha; Shylaja Hanumanthappa; Srinath Rangappa; Saravanan Janardhanan
Journal:  Oman Med J       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.